Healthcare Asia Magazine
Top News
LATEST NEWS
AI, mobile integration drive surge in smart inhaler adoptions
AI, mobile integration drive surge in smart inhaler adoptions
Rising need for personalised and remote healthcare also drives adoption.
15 hours ago
$110m funding boost to support Australians with chronic conditions
$110m funding boost to support Australians with chronic conditions
Chronic conditions cause 90% of deaths and affect most Australians.
15 hours ago
Rising CKD cases, advanced biomarkers fuel $4.8b market growth
Rising CKD cases, advanced biomarkers fuel $4.8b market growth
Market growth is expected to continue through 2034.
1 day ago
Peripheral vascular devices market to reach $15.5b by 2032
Peripheral vascular devices market to reach $15.5b by 2032
Increasing prevalence of PAD and lifestyle-related vascular disorders drives demand.
1 day ago
Global prescription drugs market to reach $2.26t by 2034
Global prescription drugs market to reach $2.26t by 2034
The Asia Pacific region is projected to register the fastest growth rate.
2 days ago
Neurological disorders, aging boost brain-computer interface market
Neurological disorders, aging boost brain-computer interface market
Government and private investment accelerates innovation.
2 days ago
Rising cases, advanced diagnostics drive biliary tract cancer market growth across 7MM
Rising cases, advanced diagnostics drive biliary tract cancer market growth across 7MM
Increasing cases were driven by aging populations and liver diseases.
2 days ago
IHH Healthcare FY2025 net profit falls 21% to $682.67m
IHH Healthcare FY2025 net profit falls 21% to $682.67m
The decrease is due to unrealised currency translation losses from a stronger ringgit.
3 days ago
Sunway Healthcare targets $4.34b market cap with Malaysia IPO
Sunway Healthcare targets $4.34b market cap with Malaysia IPO
Proceeds from the listing will partially fund its expansion.
3 days ago
Automation, continuous manufacturing drive global pharmaceutical equipment demand
Automation, continuous manufacturing drive global pharmaceutical equipment demand
It is also driven by chronic diseases and biologics production.
6 days ago
Tam Anh invests $77m in proton therapy system
Tam Anh invests $77m in proton therapy system
Deal signed during Vietnam-U.S. Comprehensive Strategic Partnership visit.
Aging population drives demand for durable medical equipment market
Aging population drives demand for durable medical equipment market
Telehealth, 3D printing, and customisation are amongst the key trends.
Hong Kong outlines ‘One plus Three’ model for life and health tech R&D
Hong Kong outlines ‘One plus Three’ model for life and health tech R&D
A headquarters for the Life and Health Technology Research Institutes will be set up.
iX Biopharma secures $52.8m US contract for pain reliever trials
iX Biopharma secures $52.8m US contract for pain reliever trials
The funding will be allocated for the late-stage development of Wafermine.
$85M funding to to boost health research, mRNA innovation in Australia
$85M funding to to boost health research, mRNA innovation in Australia
It targets serious health conditions with limited treatment options.
Forum
How quickly can hospitals expand ICU and acute-care beds to meet rising demand?
A staffing shortage makes it harder to turn added space into fully usable beds.
How can governments stop healthcare inflation from spiraling?
Asia-Pacific medical costs are set to outpace global averages this year.
How are hospitals adapting to self-guided healthcare?
Seven in eight Asian adults research treatments before seeing a doctor.
How can drugmakers stand out in a crowded immunology market?
Launching the next autoimmune therapy blockbuster is becoming harder.
Partner Content
Exclusives
Healthcare
IHH Healthcare bets on Fortis stake for Indian expansion
It plans to add 2,000 hospital beds by 2028.
Event News
Co-Written / Partner
Pureland Venture’s Chris Hardesty: Governments must sustain long-term focus on healthcare innovation, technology
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.



Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation